Organized by Roche France and Institut Roche, in coordination with the Cancéropôle Nord-Ouest, these meetings brought together more than one hundred participants (oncologists, scientists, pharmacists, etc.) with the objective of promoting the establishment of investigator networks.
In addition, the program for this 2024 edition included a presentation of the main clinical news in immuno-oncology in the various solid tumors, as well as interactive sessions and round tables of experts dealing with current topics. On this occasion, Emmanuel Lavallée and Magnus Fontes presented immuno-oncology at Roche and Magnus Fontes spoke about “How will AI become a key player in the biomedicine of tomorrow?”.
